The Glucose Never Lies® Podcast

17 – GLP-1 in Type 1 Diabetes: beyond weight loss, towards metabolic therapy?

John Pemberton Episode 17

Suggest guests or get in contact

Episode 17 — GLP-1 in Type 1 Diabetes: Beyond Weight Loss, Towards Metabolic Therapy

 Go to the Podcast page for all the notes, insights, and further reading & listening.

Subscribe to The Glucose Never Lies® and receive the Summary PDF with all the key take-home messages and practical implementation strategies. 

Support The Glucose Never Lies® Podcast
Buy Me a Coffee
💙 Donate


Guest: Professor Viral Shah, MD

  • Professor of Medicine & Director of Diabetes Clinical Research, Center for Diabetes and Metabolic Diseases, IU School of Medicine
  • Author of multiple clinical trials and consensus guidelines on GLP-1 and incretin therapies in type 1 diabetes

In this episode, John Pemberton speaks with Professor Viral Shah, a leading researcher in incretin therapies, about:

  • The unique challenges of type 1 diabetes (insulin resistance, glucagon, weight gain).
  • The evidence for GLP-1s in T1D: up to 30% insulin reduction, weight loss, and improved time in range.
  • Practical guidance for people with type 1 and healthcare professionals: insulin titration, MDI vs pump vs AID, nutrition, and risk–benefit.

Subscribe to The Glucose Never Lies® and receive the Summary PDF with all the key take-home messages and practical implementation strategies. 

Go to the Podcast page for all the notes, insights, and further reading & listening.

Related GNL Resources

  • Overcoming Insulin Resistance in T1D
  • Eight Causes of Insulin Resistance
  • Seven Ways to Combat Insulin Resistance
  • Automated Insulin Delivery Series
  • CGM Series
  • GNL Podcast Episode 14 Overcoming Insulin Resistance

People on this episode

Podcasts we love

Check out these other fine podcasts recommended by us, not an algorithm.

The Peter Attia Drive Artwork

The Peter Attia Drive

Peter Attia, MD